Wow! What a weird time it’s been. As physicians, as humans, as citizens of our local communities and work families, as parents, as children, as partners, as business owners; we have had to decide how we will show up in the face of uncertainty.
ACOFP is proud of its exceptional student members and their commitment to excellence and upholding osteopathic values. We are happy to recognize our Student Chapter Award winners and Auxiliary Student Award winners for the 2019–2020 academic year.
One of the greatest challenges of the COVID-19 pandemic will be keeping a positive team culture during this time of crisis. Therefore, it is paramount during this crisis that physician leaders are purposeful in developing a positive work culture. Here are some ways in which you can do that.
On March 19, ACOFP launched the ACOFP ’20 Virtual experience, featuring live-streaming sessions. In case you missed it, here are some video highlights from the live-streaming event.
Every morning when I go to the office, to the hospital, to nursing homes, I ask myself now, “am I doing my patients a favor?” Maybe I will make them sick. Or maybe they will make me sick. After very visit to the homeless shelter, I wonder, should I immediately go into a two-week self-isolation period? How do we do what we love professionally in the time of plague?
For COVID-19 patients, OMT procedures that are directed at augmenting lymphatic circulation should be considered. For further discussion of the treatment of patients with upper and lower respiratory tract disease, and descriptions of applicable OMT procedures, see chapters 24 and 25 in the second edition of Somatic Dysfunction in Osteopathic Family Medicine.
Connect and Communicate Turn down for what? Historically, the osteopathic profession has met challenges and adversities with renewed passion, increased vigor and a stronger and more viable spirit. When osteopathic […]
While more research is needed to implement a new standard of care, the first few studies on iron supplementation and hepcidin have had promising results. This new research can lead to a positive discussion between patient and provider. It can also give us an alternative to offer if patients simply cannot stick to the standard dosing regimen. Regarding our own education, it offers physicians a new insight into a decades-old condition.
By Katarina Lindley, DO, FACOFPIncoming Chair, ACOFP Federal & State Legislation Committee; President, Texas ACOFP As we are all aware by now, we are dealing with global outbreak of respiratory […]
In less than a month, more than 2,000 attendees—including practicing osteopathic family physicians, residents and student—will descend on the Big Easy for the 57th Annual Convention & Scientific Seminars. The […]
Cervical screening through regular Pap smears, as well as the HPV vaccine, are both incredible tools in the prevention of cervical cancer. When it comes to risk reduction for cancer development, women should be educated by their health care providers that prevention is indeed the best medicine.
When the American Osteopathic Board of Family Medicine announced the groundbreaking Early Entry Initial Certification (EEIC) pathway, I knew this was the direction I wanted to go.
Pursuing the now optional OMT portion of the board certification was an easy choice for me. I want my patients to know that beyond being trained in osteopathic medicine, I have gone through the process of having my skills reviewed and approved by a larger body—like any other board exam.
An estimated 9.4% of the United States (U.S.) population has diabetes and 33.9% of U.S. adults 18 years and older have prediabetes (Center for Disease Control, 2017). A missed or underutilized opportunity for treatment in this population is education and motivation to part take in physical activity.
There are some exciting things developing in osteopathic family medicine over the next few years. It is my hope that innovation, technology and the need for more family physicians across the country will inspire even more students and residents to choose osteopathic family medicine through 2030 and beyond.